Jul 2026
Analytical Validation of a Plasma-Based Rapid Liquid Biopsy Assay Using Next-Generation Sequencing.
The feasibility and validation of a two-day TAT NGS-based cfTNA assay that can potentially reduce time-to-treatment is reported that can potentially reduce time-to-treatment.
S. Roy-Chowdhuri, Ana Galán-Cobo, N. Agarwal et al.
· Journal of Molecular Diagnos... · 0 citations